References for
"Double Breast Cancer Survival Rates"
Video
Note: references ending in .pdf go directly to the full article in pdf format
1. American Cancer Society: (1) recommendations to lower breast cancer recurrence and (2) ACS’s opinion on vitamin supplements for lowering risk for breast cancer recurrence
2. Heer E, Harper A, Escandor N, et al. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health 2020; 8:e1027–37.
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30215-1/fulltext
3. Lim ST, Jeon YW, Gwak H, et al. Clinical implications of serum 25-hydroxyvitamin D status after 5-year adjuvant endocrine therapy for late recurrence of hormone receptor-positive breast cancer. J Breast Cancer 2020; 23:498-508.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604371/pdf/jbc-23-498.pdf
4. Peng C, Heng YJ, Lu D, et al. Pre-diagnostic 25-hydroxyvitamin D concentrations in relation to tumor molecular alterations and risk of breast cancer recurrence. Cancer Epidemiol Biomarkers Prev. 2020; 29:1253–63.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284927/pdf/nihms-1581718.pdf
5. Radom A, Wędrychowicz A, Pieczarkowski S, et al. Effect of Selected Factors on the Serum 25(OH)D Concentration in Women Treated for Breast Cancer. Nutrients 2021;13:564-81.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915136/pdf/nutrients-13-00564.pdf
6. Vrieling A, Hein R, Abbas S, et al. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Research 2011; 13:R74-82.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236338/pdf/bcr2920.pdf